Market Vectors® Biotech ETF (BBH)

135.32
Delayed Data
As of May 22
 -0.045 / -0.03%
Today’s Change
87.43
Today|||52-Week Range
140.72
+17.28%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Performance

1 month+0.48% 3 years+43.63%
3 months+6.41% 5 years--
1 year+52.21% Since inception+48.31%
Data through 05/23/2015

Quote Details

Previous close$135.37
Open day’s range134.97 – 135.78
Net asset value (NAV)135.33 (05/22/2015)
Daily volume88,342
Average volume (3 months)136,714
Data as of 3:59pm ET, 05/22/2015

Peer Comparisonvs. Health ETFs

 BBHCategory
Performance 5-yr return--+22.89%
Expense Gross exp ratio0.41%0.47%
Risk 5 year sharpe ratio--1.46
Net assets$756.0M$1.7B
Average market cap$37.2B$35.4B
Average P/E26.624.6
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences14.87%
AMGN Amgen12.21%
CELG Celgene10.40%
BIIB Biogen8.02%
REGN Regeneron Pharmaceuticals5.57%
VRTX Vertex Pharmaceuticals Inc4.63%
BMRN Biomarin Pharmaceutical Inc4.58%
ILMN Illumina Inc4.54%
ALXN Alexion Pharmaceuticals Inc4.36%
MDVN Medivation Inc4.01%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers